Arthritis At Home (+ On the Go)

Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications

April 25, 2024 Arthritis Consumer Experts Season 1 Episode 89
Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications
Arthritis At Home (+ On the Go)
More Info
Arthritis At Home (+ On the Go)
Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications
Apr 25, 2024 Season 1 Episode 89
Arthritis Consumer Experts

In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Derin Karacabeyli, rheumatology resident at the University of British Columbia. Dr. Karacabeyli is studying the effects of treating metabolic comorbidities like obesity and type 2 diabetes on patients with immune-mediated inflammatory diseases. In this interview, he shares the work he is conducting to look at the potential risks and benefits for inflammatory arthritis patients taking a new class of medications used in type 2 diabetes therapy.

Additional learning resources

Show Notes

In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Derin Karacabeyli, rheumatology resident at the University of British Columbia. Dr. Karacabeyli is studying the effects of treating metabolic comorbidities like obesity and type 2 diabetes on patients with immune-mediated inflammatory diseases. In this interview, he shares the work he is conducting to look at the potential risks and benefits for inflammatory arthritis patients taking a new class of medications used in type 2 diabetes therapy.

Additional learning resources